Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 Dec;9(4):339-42.
doi: 10.1007/s10238-009-0053-1. Epub 2009 May 21.

Diverse phenotypic and genotypic presentation of RAG1 mutations in two cases with SCID

Affiliations

Diverse phenotypic and genotypic presentation of RAG1 mutations in two cases with SCID

Neslihan Edeer Karaca et al. Clin Exp Med. 2009 Dec.

Abstract

Severe combined immunodeficiencies (SCID) comprise a spectrum of genetic defects that involve both humoral and cellular immunities. Defects in recombinating activating gene 1 (RAG1), RAG2, Artemis, or LIG4 can disrupt V(D)J recombination. Defective V(D)J recombination of the T and B cell receptors is responsible for T(-)B(-)NK(+)SCID. Amorphic mutations in RAG1 and RAG2 cause T(-)B(-)NK(+)SCID, whereas hypomorphic mutations cause an immunodeficency characterized by oligoclonal expansion of TCRgammadelta T cells, severe CMV infection and autoimmunity. First patient is a typical T(-)B(-)NK(+)SCID with clinical and immunologic findings while the second is atypical with normal immunoglobulin levels, CD4 lymphopenia, elevated TCRgammadelta T cells, persistent CMV infection, and autoimmune hemolytic anemia. These cases are presented to emphasize that mutations in RAG1 gene may lead to a diverse spectrum of clinical and immunologic findings while hypomorphic mutations may be related with autoimmunity and refractory CMV infection during infancy.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Blood. 2005 Sep 15;106(6):2099-101 - PubMed
    1. J Immunol. 2007 Dec 15;179(12):8332-40 - PubMed
    1. Cell. 2001 Apr 20;105(2):177-86 - PubMed
    1. Allergol Int. 2006 Jun;55(2):115-9 - PubMed
    1. Blood. 2008 Jan 1;111(1):271-4 - PubMed

MeSH terms

Substances

LinkOut - more resources